These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 16740661)
1. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Raqib R; Sarker P; Bergman P; Ara G; Lindh M; Sack DA; Nasirul Islam KM; Gudmundsson GH; Andersson J; Agerberth B Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9178-83. PubMed ID: 16740661 [TBL] [Abstract][Full Text] [Related]
2. Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. Sarker P; Ahmed S; Tiash S; Rekha RS; Stromberg R; Andersson J; Bergman P; Gudmundsson GH; Agerberth B; Raqib R PLoS One; 2011; 6(6):e20637. PubMed ID: 21673991 [TBL] [Abstract][Full Text] [Related]
3. Inducing endogenous antimicrobial peptides to battle infections. Zasloff M Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8913-4. PubMed ID: 16754884 [No Abstract] [Full Text] [Related]
4. Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. Raqib R; Sarker P; Mily A; Alam NH; Arifuzzaman AS; Rekha RS; Andersson J; Gudmundsson GH; Cravioto A; Agerberth B BMC Infect Dis; 2012 May; 12():111. PubMed ID: 22574737 [TBL] [Abstract][Full Text] [Related]
5. Defending the epithelium. Zasloff M Nat Med; 2006 Jun; 12(6):607-8. PubMed ID: 16760999 [No Abstract] [Full Text] [Related]
6. Battle and balance at mucosal surfaces--the story of Shigella and antimicrobial peptides. Gudmundsson GH; Bergman P; Andersson J; Raqib R; Agerberth B Biochem Biophys Res Commun; 2010 May; 396(1):116-9. PubMed ID: 20494122 [TBL] [Abstract][Full Text] [Related]
7. Double-stranded RNA induces cathelicidin expression in the intestinal epithelial cells through phosphatidylinositol 3-kinase-protein kinase Cζ-Sp1 pathway and ameliorates shigellosis in mice. Ta A; Thakur BK; Dutta P; Sinha R; Koley H; Das S Cell Signal; 2017 Jul; 35():140-153. PubMed ID: 28343946 [TBL] [Abstract][Full Text] [Related]
8. Shigellae control the Gates of LL. Lehrer R Nat Med; 2001 Feb; 7(2):158-9. PubMed ID: 11175842 [No Abstract] [Full Text] [Related]
9. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs. Jiang W; Sunkara LT; Zeng X; Deng Z; Myers SM; Zhang G Peptides; 2013 Dec; 50():129-38. PubMed ID: 24140860 [TBL] [Abstract][Full Text] [Related]
10. Role of nuclear hormone receptors in butyrate-mediated up-regulation of the antimicrobial peptide cathelicidin in epithelial colorectal cells. Schwab M; Reynders V; Shastri Y; Loitsch S; Stein J; Schröder O Mol Immunol; 2007 Mar; 44(8):2107-14. PubMed ID: 17055059 [TBL] [Abstract][Full Text] [Related]
11. Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a. Rabbani GH; Albert MJ; Rahman H; Islam M; Mahalanabis D; Kabir I; Alam K; Ansaruzzaman M Infect Immun; 1995 Nov; 63(11):4350-7. PubMed ID: 7591070 [TBL] [Abstract][Full Text] [Related]
12. MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis. Cobo ER; Kissoon-Singh V; Moreau F; Holani R; Chadee K Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069814 [TBL] [Abstract][Full Text] [Related]
13. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Hase K; Eckmann L; Leopard JD; Varki N; Kagnoff MF Infect Immun; 2002 Feb; 70(2):953-63. PubMed ID: 11796631 [TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon Epithelia. Sarker P; Mily A; Mamun AA; Jalal S; Bergman P; Raqib R; Gudmundsson GH; Agerberth B Antibiotics (Basel); 2014 Jul; 3(3):353-74. PubMed ID: 27025750 [TBL] [Abstract][Full Text] [Related]
15. Treatment with phenylbutyrate in a pre-clinical trial reduces diarrhea due to enteropathogenic Escherichia coli: link to cathelicidin induction. Al-Mamun A; Mily A; Sarker P; Tiash S; Navarro A; Akter M; Talukder KA; Islam MF; Agerberth B; Gudmundsson GH; Cravioto A; Raqib R Microbes Infect; 2013 Nov; 15(13):939-50. PubMed ID: 24016414 [TBL] [Abstract][Full Text] [Related]
16. Potent Inducers of Endogenous Antimicrobial Peptides for Host Directed Therapy of Infections. Ottosson H; Nylén F; Sarker P; Miraglia E; Bergman P; Gudmundsson GH; Raqib R; Agerberth B; Strömberg R Sci Rep; 2016 Nov; 6():36692. PubMed ID: 27827460 [TBL] [Abstract][Full Text] [Related]
17. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis. Niyogi SK Clin Microbiol Infect; 2007 Dec; 13(12):1141-3. PubMed ID: 17953700 [TBL] [Abstract][Full Text] [Related]
18. An Oral Inoculation Infant Rabbit Model for Kuehl CJ; D'Gama JD; Warr AR; Waldor MK mBio; 2020 Jan; 11(1):. PubMed ID: 31964739 [No Abstract] [Full Text] [Related]
19. Treatment with Entinostat Heals Experimental Cholera by Affecting Physical and Chemical Barrier Functions of Intestinal Epithelia. Sarker P; Banik A; Stromberg R; Gudmundsson GH; Raqib R; Agerberth B Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438947 [TBL] [Abstract][Full Text] [Related]
20. A murine model of diarrhea, growth impairment and metabolic disturbances with Q S Medeiros PH; Ledwaba SE; Bolick DT; Giallourou N; Yum LK; Costa DVS; Oriá RB; Barry EM; Swann JR; Lima AÂM; Agaisse H; Guerrant RL Gut Microbes; 2019; 10(5):615-630. PubMed ID: 30712505 [No Abstract] [Full Text] [Related] [Next] [New Search]